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Abstract
Excitatory interneurons account for the majority of dorsal horn neurons, and are required for
perception of normal and pathological pain. We have identified largely non-overlapping popula-
tions in laminae I-III, based on expression of substance P, gastrin-releasing peptide,
neurokinin B, and neurotensin. Cholecystokinin (CCK) is expressed by many dorsal horn neu-
rons, particularly in the deeper laminae. Here, we have used immunocytochemistry and in situ
hybridization to characterize the CCK cells. We show that they account for ~7% of excitatory
neurons in laminae I-II, but between a third and a quarter of those in lamina III. They are largely
separate from the neurokinin B, neurotensin, and gastrin-releasing peptide populations, but
show limited overlap with the substance P cells. Laminae II-III neurons with protein kinase Cγ
(PKCγ) have been implicated in mechanical allodynia following nerve injury, and we found that
around 50% of CCK cells were PKCγ-immunoreactive. Neurotensin is also expressed by PKCγ
cells, and among neurons with moderate to high levels of PKCγ, ~85% expressed CCK or neuro-
tensin. A recent transcriptomic study identified mRNA for thyrotropin-releasing hormone in a
specific subpopulation of CCK neurons, and we show that these account for half of the
CCK/PKCγ cells. These findings indicate that the CCK cells are distinct from other excitatory
interneuron populations that we have defined. They also show that PKCγ cells can be assigned
to different classes based on neuropeptide expression, and it will be important to determine the
differential contribution of these classes to neuropathic allodynia.
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1 | INTRODUCTION
The spinal dorsal horn contains numerous interneurons, which are
involved in processing somatosensory information (Abraira & Ginty,
2013; Braz, Solorzano, Wang, & Basbaum, 2014; Peirs & Seal, 2016;
Todd, 2010). These can be divided into two broad classes: excitatory
and inhibitory cells (Todd, 2010, 2017). In the mouse, excitatory (glu-
tamatergic) interneurons account for ~75% of the neurons in laminae
I-II and 60% of those in lamina III (Polgár, Durrieux, Hughes, & Todd,
2013). Although the roles of these cells are not fully understood, it
has been shown those in laminae I-II are required for acute mechanical
pain and development of mechanical allodynia (Christensen et al.,
2016; Duan et al., 2014; Wang et al., 2013).†Maria Gutierrez-Mecinas and Andrew M. Bell contributed equally to this study.
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Dorsal horn excitatory interneurons are functionally diverse, and
there have been many attempts to define distinct populations among
these cells (Todd, 2017). Most recent studies have used neurochemi-
cal criteria, in particular the expression of neuropeptides. We have
identified four largely non-overlapping populations in laminae I-II,
based on the expression of neurotensin, neurokinin B (NKB), sub-
stance, P and gastrin-releasing peptide (GRP), and have shown that
between them, they account for over half of the excitatory interneu-
rons in this region (Gutierrez-Mecinas et al., 2017; Gutierrez-Mecinas,
Furuta, Watanabe, & Todd, 2016). While the neurotensin and NKB
cells can be identified by immunocytochemistry, we revealed the sub-
stance P cells by spinal injection of adeno-associated viruses (AAVs)
coding for Cre-dependent expression cassettes into mice in which Cre
recombinase was knocked into Tac1 (the gene for substance P). The
GRP cells were identified by the presence of enhanced green fluores-
cent protein (eGFP) in a BAC transgenic mouse line (GRP::eGFP) in
which eGFP is expressed under control of the GRP promoter
(Gutierrez-Mecinas, Watanabe, & Todd, 2014; Mishra & Hoon, 2013;
Solorzano et al., 2015). Neurotensin and NKB neurons, which are con-
centrated in inner lamina II (lamina IIi) and lamina III, partly correspond
to cells that express protein kinase Cγ (PKCγ; Gutierrez-Mecinas et al.,
2016). PKCγ-expressing cells are of particular interest, because they
are thought to form part of a circuit that is responsible for mechanical
allodynia (Lu et al., 2013; Malmberg, Chen, Tonegawa, & Basbaum,
1997; Miraucourt, Dallel, & Voisin, 2007).
A recent transcriptomic study by Häring et al. (2018) identified
15 classes of excitatory dorsal horn neuron, and their results are
broadly consistent with the findings described above, as their classes
include cells with high levels of the mRNAs for neurotensin, NKB, and
substance P. Another peptide that featured in their classification
scheme was cholecystokinin (CCK), which was expressed in three sep-
arate populations of excitatory neurons. Early reports had indicated
that neurons with CCK mRNA were most numerous in lamina III and
scattered through the other laminae (Abelson & Micevych, 1991;
Cortes, Arvidsson, Schalling, Ceccatelli, & Hokfelt, 1990; Schiffmann,
Teugels, Halleux, Menu, & Vanderhaeghen, 1991), while a recent
study found that CCK defined a specific population of excitatory neu-
rons in the deeper laminae of the dorsal horn (Abraira et al., 2017).
The first aim of the present study was to estimate the proportion
of excitatory neurons in laminae I-III that expressed CCK. This was
achieved with two approaches: immunocytochemistry with an anti-
body against the precursor pro-CCK (Booker et al., 2017) and
multiple-labeling fluorescent in situ hybridization. We also examined
the extent of overlap with the four populations of excitatory interneu-
rons that we had identified in the superficial dorsal horn. Our prelimi-
nary studies indicated that some pro-CCK-positive neurons in laminae
II-III showed strong PKCγ-immunoreactivity, and we therefore com-
pared expression of neurotensin, CCK, and PKCγ, because neuroten-
sin is also expressed by cells with high levels of PKCγ in this region
(Gutierrez-Mecinas et al., 2016). Finally, because Häring et al. (2018)
reported that one of the CCK populations could be identified based
on expression of thyrotropin-releasing hormone (TRH), we looked for
cells that contained mRNAs for both CCK and TRH and tested
whether these corresponded to PKCγ-expressing neurons.
2 | MATERIALS AND METHODS
2.1 | Animals
All experiments were approved by the Ethical Review Process Appli-
cations Panel of the University of Glasgow, and were performed in
accordance with the UK Animals (Scientific Procedures) Act 1986.
Five wild-type C57BL/6 mice (either sex, 18–27 g) and 3 GRP::
eGFP mice (Gutierrez-Mecinas et al., 2014; either sex, 19–27 g) were
deeply anesthetized with pentobarbitone (20 mg i.p.) and perfused
through the left cardiac ventricle with a fixative consisting of 4%
freshly depolymerized formaldehyde in phosphate buffer. Mid-lumbar
spinal cord segments (L3–L5) were removed and postfixed for 2 hr at
4 C in the same fixative before being processed for immunocyto-
chemistry. Spinal cord tissue was also obtained from three male
Tac1Cre mice (19–22 g; Harris et al., 2014) that had received intrasp-
inal injections of AAV (serotype 1) coding for Cre-dependent eGFP
(AAV.flex.eGFP; Penn Vector Core, Philadelphia, PA) into the lumbar
enlargement, and had been used in a previous study (Gutierrez-
Mecinas et al., 2019). These mice had survived 8 days after the spinal
injection before being perfused with the same fixative. Transverse
sections from segments that included the injection sites were pro-
cessed for immunocytochemistry.
Three wild-type C57BL/6 mice (either sex, 18–20 g) were used
for in situ hybridization experiments. The mice were decapitated
under deep isoflurane anesthesia and spinal cords were removed and
rapidly frozen on dry ice.
2.2 | Immunocytochemistry, confocal microscopy,
and analysis
Transverse spinal cord sections 60 μm thick were cut from the
perfusion-fixed tissue with a vibrating blade microtome and immersed
in 50% ethanol for 30 min to enhance antibody penetration. These
were then reacted for multiple-labeling immunofluorescence staining
as described previously (Gutierrez-Mecinas et al., 2016). The primary
antibodies used in this part of the study are listed in Table 1. Unless
stated otherwise, sections were incubated for 3 days at 4 C in pri-
mary antibodies diluted in PBS that contained 0.3 M NaCl, 0.3% Tri-
ton X-100 and 5% normal donkey serum, and then overnight in
appropriate species-specific secondary antibodies (Jackson Immunore-
search, West Grove, PA) that were raised in donkey and conjugated to
Alexa 488, Alexa 647, Rhodamine Red, Pacific Blue or biotin. All sec-
ondary antibodies were used at 1:500 (in the same diluent), apart from
those conjugated to Rhodamine Red or Pacific Blue, which were
diluted to 1:100 and 1:200, respectively. Biotinylated secondary anti-
bodies were detected with either Pacific Blue conjugated to avidin
(1:1,000; Life Technologies, Paisley, UK) or with a tyramide signal
amplification (TSA) method (TSA kit tetramethylrhodamine
NEL702001, PerkinElmer Life Sciences, Boston, MA). The TSA reac-
tion was used to detect the NKB precursor preprotachykinin B
(PPTB), as this method can be used to reveal cell bodies of NKB-
expressing dorsal horn neurons (Polgár, Furuta, Kaneko, & Todd,
2006). Following the immunocytochemical reaction, sections were
mounted in antifade medium and stored at −20 C.
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Sections from the GRP::eGFP mice were reacted with primary
antibodies against eGFP, pro-CCK, and NeuN (mouse antibody), and
following incubation in secondary antibodies, they were counter-
stained with 406-diamidino-2-phenylindole (DAPI) to label cell nuclei.
Sections from the wild-type mice were reacted with three different
combinations of primary antibodies: (a) pro-CCK, neurotensin, PKCγ,
and NeuN (mouse antibody); (b) pro-CCK, PPTB, NeuN (mouse
antibody); (c) pro-CCK, Pax2, NeuN (mouse antibody). For the third
reaction, a sequential staining protocol was used, because both the
pro-CCK and Pax2 antibodies are raised in rabbit. In this case, sections
were initially incubated in pro-CCK and NeuN antibodies, which were
revealed with fluorescent secondary antibodies conjugated to Alexa
488 and Alexa 647, respectively. They were then treated with uncon-
jugated Fab’ donkey anti-rabbit IgG fragment for 6 hr to saturate bind-
ing sites for rabbit IgG, before being incubated for 2 days in the Pax2
antibody, which was subsequently revealed with secondary antibody
conjugated to Rhodamine Red. Tissue from the Tac1Cre mice that had
received intraspinal injections of AAV.flex.eGFP was incubated in anti-
bodies against pro-CCK and NeuN (guinea pig antibody).
Sections were scanned with a Zeiss LSM 710 confocal micro-
scope with Argon multiline, 405 nm diode, 561 nm solid state, and
633 nm HeNe lasers. Confocal image stacks were obtained through a
40× oil immersion lens (numerical aperture 1.3) with the confocal
aperture set to 1 Airy unit. In each case, the entire mediolateral width
of laminae I-III was scanned to generate z-series of at least 20 μm
(and in many cases the full thickness of the section), with a z-
separation of 1 μm. Unless otherwise stated, for each antibody combi-
nation, two sections from each of three mice were selected for scan-
ning. To avoid bias, this selection was made before the pro-CCK-
immunoreactivity was viewed. Confocal scans were analyzed with
Neurolucida for Confocal software (MBF Bioscience, Williston, VT).
The lamina II-III border was identified from the distribution of NeuN
immunoreactivity, based on the relatively low neuronal packing den-
sity in lamina IIi. The lamina I-II border was assumed to be 20 μm from
the dorsal edge of the dorsal horn (Dickie et al., 2019). The lamina
III/IV border was identified by the somewhat lower packing density of
neurons in lamina IV (Molander, Xu, & Grant, 1984).
To determine the proportion of neurons in laminae I-III that are
pro-CCK-immunoreactive, we used a modification of the optical dis-
sector method (Polgár, Gray, Riddell, & Todd, 2004) on sections from
the three GRP::eGFP mice. The reference and look-up sections were
set 10 μm apart and initially only the NeuN and DAPI channels were
viewed. All intervening optical sections were examined, and neuronal
nuclei (NeuN+/DAPI+ structures) were selected if their bottom sur-
face lay between the reference and look-up sections. These were then
plotted onto an outline drawing of the dorsal horn. The pro-CCK
channel was then switched on and the presence or absence of staining
was determined for each selected neuron. These sections were also
used to assess whether pro-CCK was expressed by any GRP-eGFP
cells. For this analysis, we plotted the location of all pro-CCK-
immunoreactive cells within the full depth of the confocal z-series and
then checked for the presence of eGFP in these cells.
To test whether any of the CCK cells were inhibitory interneu-
rons, we identified pro-CCK-positive neurons in laminae I-III through
a depth of at least 24 μm in sections reacted with the Pax2 antibody
from each of three mice. We then viewed the Pax2 channel and deter-
mined whether any of the selected cells had Pax2-immunoreactive
nuclei.
To look for evidence of coexpression of CCK and NKB, we ana-
lyzed sections reacted for pro-CCK and the NKB precursor PPTB.
Pro-CCK-immunoreactive neurons were identified throughout the full
thickness of sections from three mice, and then the presence or
absence of PPTB was noted.
To determine whether there was overlap between CCK and sub-
stance P populations, we analyzed sections from the three Tac1Cre
mice that had been injected with AAV.flex.eGFP. All pro-CCK cells
were identified throughout the full thickness of sections from three
mice, and we then looked for the presence of eGFP (representing
Tac1 expression) in these cells. Because we found some overlap
between these populations, we then reversed the procedure by iden-
tifying all eGFP-positive cells and determining whether they were
pro-CCK-immunoreactive.
Sections reacted with antibodies against pro-CCK, neurotensin,
and PKCγ were used to look for co-expression of pro-CCK and neuro-
tensin, and also to determine the relationship of both peptides to
TABLE 1 Antibodies used in this study
Antibody Host and type Antigen Supplier/reference
Catalogue
number RRID Dilution
Pro-CCK Rabbit polyclonal Amino acids 107–115 of
mouse pro-CCK
Booker et al. (2017) RRID:AB_2571674 1,000
NeuN Mouse monoclonal Purified cell nuclei
from mouse brain
Millipore MAB377 RRID:AB_2298772 1:500
NeuN Guinea pig polyclonal Amino acids 1–97 of
mouse Fox-3
Synaptic Systems 266004 RRID:AB_2619988 1:1,000
Neurotensin Rat polyclonal Synthetic neurotensin Porteous et al. (2011) RRID:AB_2314928 1:1,000
PKCγ Guinea pig polyclonal Amino acids 684–697
of mouse PKCγ
Yoshida et al. (2006) RRID:AB_2571826 1:1,000
PPTB Guinea pig polyclonal Amino acids 95–116
of rat PPTB
Kaneko, Murashima,
Lee, and Mizuno (1998)
1:5,000
Pax2 Rabbit polyclonal Amino acids 188–385
of mouse Pax2
Life Technologies 716000 RRID:AB_2533990 1:500
eGFP Chicken Recombinant full-length eGFP Abcam Ab13970 RRID:AB_300798 1:1,000
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PKCγ. In this case, three sections from each of three mice were exam-
ined through their full thickness. Initially, all pro-CCK cells were
selected and these were then tested for the presence of neurotensin
and PKCγ. In a separate analysis, we viewed the PKCγ channel and
identified all of the neurons that showed strong or moderate levels of
PKCγ immunoreactivity and had cell bodies that were completely con-
tained within the section. We then switched on the pro-CCK and neu-
rotensin channels and recorded the presence or absence of these
peptides in each of the selected PKCγ cells.
2.3 | Fluorescent in situ hybridization histochemistry
Multiple-labeling fluorescent in situ hybridization was performed with
RNAscope probes and RNAscope fluorescent multiplex reagent kit
320850 (ACD BioTechne; Newark, CA). Fresh frozen lumbar spinal
cord segments from three wild-type mice was embedded in OCT
mounting medium and cut into 12 μm thick transverse sections with a
cryostat (Leica CM1850 or CM1860; Leica; Milton Keynes, UK). These
were mounted non-sequentially (such that sections on the same slide
were at least four apart) onto SuperFrost Plus slides (48311-703;
VWR; Lutterworth, UK) and air-dried. Reactions were carried out
according to the manufacturer's recommended protocol. The probes
used in this study, and the proteins/peptides that they correspond to,
are listed in Table 2. Sections from three mice were incubated in the
following probe combinations: (a) Cck, Slc17a6; (b) Prkcg, Cck, Trh;
(c) Prkcg, Cck, Nts; (d) Tac1, Cck, Tac2; (e), Prkcg, Trh, Nts. In each
case, the first listed probe was revealed with Alexa 488, the second
with Atto 550, and the third with Alexa 647. Sections were mounted
with Prolong-Glass anti-fade medium with NucBlue (Hoechst 33342)
(ThermoFisher Scientific, Paisley, UK). Positive and negative control
probes were also tested on other sections (Table 2).
Sections were scanned with a Zeiss LSM 710 confocal micro-
scope through the 40× oil-immersion lens with the confocal aperture
set to 1 Airy unit. In each case, a single optical plane through the mid-
dle of the section was scanned (Häring et al., 2018), using tile scanning
to include the whole of laminae I-IV. Five sections were scanned per
animal except for the analysis of reactions (c) and (d) where three sec-
tions per animal were used. Sections were selected prior to viewing in
situ hybridization florescence, to avoid bias.
Semiautomated analysis of transcript numbers per nucleus was
conducted using the HALO FISH v1.1 module for RNAScope (Indica
labs, Inc., Corrales). The locations of laminar boundaries were added
to the images as described above, except that nuclear staining rather
than NeuN was used to determine packing density. Recognition and
segmentation of individual nuclei was performed based on NucBlue
staining and an additional 1 μm perimeter was added to each nucleus
to allow detection of perinuclear transcripts. This additional perimeter
was omitted where cells were directly adjacent to each other. Any
areas with poor nuclear segmentation were excluded manually from
the analysis following examination of each segmented section.
Single RNA transcripts for each target gene appeared as individual
puncta. Automatic transcript recognition was conducted with the
HALO software at an analysis magnification of 1.2. Detection contrast
and minimum intensity settings for each transcript were adjusted in
real time until the segmented mark-up accurately represented the
confocal image. The number of transcripts per cell was derived from
the product of the intensity and area of the transcript florescence
within each nucleus and divided by a constant. This constant was ini-
tially set to the manufacturer's recommended value but was adjusted
manually based on inspection of the derived data in several cells to
ensure that the calculated transcript number accurately reflected that
seen in the confocal image.
Data output following analysis consisted of manual inspection of
the section to ensure accuracy, followed by export of a table contain-
ing each individual cell's transcript numbers. This was further analyzed
in Microsoft Excel. Cells were defined as positive for expression of a
given gene if they contained greater than four transcripts. Colocaliza-
tion of expression in cells was quantified by generating pivot contin-
gency tables.
2.4 | Antibody characterization
Details of the primary antibodies that were used in this study are
given in Table 1. Specificity of the pro-CCK antibody has been dem-
onstrated by showing that it stains identical cells to those detected by
fluorescent in situ hybridization with a probe against CCK mRNA in
mouse cortex and hippocampus (Booker et al., 2017). The mouse
monoclonal antibody NeuN, which was generated against cell nuclei
TABLE 2 mRNAscope probes
Probe Protein/peptide
Channel
numbers
Catalogue
numbers
Z-pair
number Target region
Cck CCK 1, 2 402271 12 23–679
Slc17a6 VGLUT2 2 319171 20 1,986–2,998
Prkcg PKCγ 1 417911 20 685–2,438
Trh TRH 2, 3 436811 20 128–1,280
Nts Neurotensin 3 420441 20 2–1,188
Tac1 Substance P 1 410351 15 20–1,034
Tac2 NKB 3 446391 15 15–684
RNAscope multiplex
positive control
(Polr2a, Ppib, Ubc)
Polr2a: DNA-directed RNA
polymerase II subunit RPB1;
Ppib: Peptidyl-prolyl cis-trans
isomerase B; Ubc: Polyubiquitin-C
1,2,3 320881 20
15
n/a
2,802–3,678
98–856
34–860
RNAscope multiplex
negative control (dapB)
dapB: 4-hydroxy-tetrahydrodipicolinate
reductase (derived from Bacillus subtilis)
1,2,3 320871 10 414–862
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extracted from mouse brain, was found to react with a protein specific
to neurons (Mullen, Buck, & Smith, 1992), and this has subsequently
been identified as the splicing factor Fox-3 (Kim, Adelstein, &
Kawamoto, 2009). We have found that the guinea-pig NeuN antibody
stains the same cells as the mouse antibody (Dickie et al., 2019).
Staining with the neurotensin antibody is identical to that seen with a
well-characterized rabbit neurotensin antibody, and is blocked by pre-
incubation with 10−4 M neurotensin (Porteous et al., 2011). The PKCγ
antibody recognizes a band of the appropriate molecular weight on
western blots from wild-type, but not PKCγ−/− mice (Yoshida et al.,
2006). The PPTB antibody recognizes PPTB, but not PPTA, NKB, or
substance P on dot blots, and staining is blocked by preincubation
with the immunizing peptide. The Pax2 antibody recognizes bands of
the appropriate molecular weight on western blots of mouse embry-
onic kidney (Dressler & Douglass, 1992). Staining with the eGFP anti-
body shows an identical distribution to that of the native fluorescent
protein in tissues.
2.5 | Specificity of fluorescent in situ hybridization
All neurons were labeled with the positive control probes (which
detect mRNAs for ubiquitously expressed proteins), while none were
labeled with the negative control probe (which detects a bacterial
enzyme).
2.6 | Figures
Figures were composed with Adobe Photoshop (CS6). Image bright-
ness and contrast were adjusted using the levels setting.
3 | RESULTS
3.1 | Expression of CCK by excitatory neurons in the
dorsal horn
In transverse sections immunostained for pro-CCK, labeling was seen
in the perikaryal cytoplasm of neurons. These immunoreactive neu-
rons were particularly numerous in the deep dorsal horn (laminae III-
V), and were scattered at lower density in laminae I and II (Figure 1).
Quantitative results obtained with the disector method from three
mice are shown in Table 3. Pro-CCK-immunoreactive cells accounted
for ~5% of all neurons in laminae I-II and 15% of those in lamina III. To
test whether CCK cells in laminae I-III were excitatory or inhibitory,
we compared Pax2 and pro-CCK immunostaining in sections from
three wild-type mice. Altogether, 247 pro-CCK cells were identified
(76–95 per mouse) and none of these had Pax2 immunoreactivity in
the nucleus (Figure 2), indicating that they are all excitatory neurons.
We have previously determined the proportions of neurons in laminae
I-III of the mouse dorsal horn that lack immunoreactivity for GABA
and glycine, and are therefore presumably excitatory neurons (Polgár
et al., 2013). Based on these results, we estimate that pro-CCK can be
detected in 6.9, 6.7, and 24.7% of the excitatory neurons in laminae I,
II, and III, respectively (Table 3). Laminae I-II are often considered
together as the superficial dorsal horn, and pro-CCK-immunoreactive
cells would account for 6.8% of the excitatory neurons in this region.
Quantitative results for the in situ hybridization analysis of
VGLUT2 and CCK in sections processed with probes directed against
Slc17a6 (VGLUT2) and Cck mRNAs are shown in Table 4, and an
example of the labeling is shown in Figure 3. As expected, the vast
majority of cells that were positive for Cck mRNA also contained
FIGURE 1 Pro-cholecystokinin (CCK) immunoreactivity in the mouse dorsal horn. (a) A maximum intensity projection of 27 confocal optical
sections (1 μm z-separation) showing immunostaining with the pro-CCK antibody in the dorsal horn. Brightly labeled profiles represent perikaryal
staining. (b) The same field showing both NeuN (magenta) and pro-CCK (green). The dashed line shows the approximate position of the lamina
II/III border. The rectangle indicates the region shown in the inset. Pro-CCK-immunoreactive cells are scattered throughout laminae I-II, but are
particularly numerous in lamina III. Inset: The relationship between pro-CCK and NeuN staining can be clearly seen in a maximum intensity
projection of three optical sections. Scale bar = 100 μm [Color figure can be viewed at wileyonlinelibrary.com]
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VGLUT2 mRNA (93 and 98% for laminae I-II and lamina III, respec-
tively). These accounted for 7% of the VGLUT2+ cells in laminae I-II
and for 36% of those in lamina III. Although we did not formally ana-
lyze the dorsal horn below lamina III, we also noted that ~30% of the
VGLUT2+ cells in the region corresponding to lamina IV were also
CCK+.
The in situ hybridization analysis was based on profile counts
(rather than stereology) and there may therefore be a bias toward
larger neurons, which are more likely to have been included in
the optical section analyzed (Guillery, 2002). However, the close
agreement between the estimates of excitatory neurons that are
CCK-positive in the superficial dorsal horn (6.8% with immunocyto-
chemistry, 7.3% with in situ hybridization) suggests that this did not
have an impact on our estimates in this region. The proportion of lam-
ina III excitatory neurons in which Cck mRNA was detected was
somewhat higher than our estimate of the proportion that were pro-
CCK-immunoreactive (36% compared to 25%). This discrepancy could
have resulted from a size bias, but may have been due to our failure
to detect pro-CCK in some of the CCK-expressing neurons in this
lamina.
3.2 | CCK is not expressed by PPTB-positive or
GRP-eGFP neurons
In the sections from the three GRP::eGFP mice, we identified an aver-
age of 129 (116–152) pro-CCK-immunoreactive cells in laminae I-III
and all except two of these cells (both located in lamina III) were
eGFP-negative (Figure 4), indicating that CCK is very seldom
expressed in GRP-eGFP neurons.
In sections from three wild-type mice that had been immunor-
eacted for PPTB and pro-CCK, we identified a mean of 95 pro-CCK-
immunoreactive cells (range 80–115) in laminae I-III in sections from
TABLE 3 Percentages of neurons in laminae I-III that were pro-CCK-immunoreactive
Number of neurons
counted
Pro-CCK-
immunoreactive
cells
% of neurons
that were pro-CCK-
immunoreactive
% of neurons
that are GABA/
glycine-negativea
Estimated % of
excitatory neurons
that contain pro-CCK
I 101 (72–116) 5 (3–8) 4.8 (3.5–6.9) 69.5 6.9
II 284.3 (207–339) 15 (9–26) 5.1 (3.3–7.7) 75.8 6.7
III 236.7 (187–278) 36.3 (28–46) 15.4 (12.6–18.8) 62.4 24.7
In each case, the mean values for the three mice are shown, with the range in brackets.
a The percentages of neurons in each lamina that lack immunoreactivity for GABA and glycine are taken from four wild-type C57BL/6 mice examined by
Polgár et al. (2013).
FIGURE 2 Lack of Pax2 immunoreactivity in the nuclei of pro-cholecystokinin (CCK)-positive cells. These images are from a section that had
been reacted with rabbit pro-CCK antibody (revealed with Alexa 488) and mouse NeuN antibody (revealed with Alex 647). The section was
subsequently reacted with Pax2 antibody (also raised in rabbit), which was revealed with Rhodamine Red. (a) Staining in the Alexa 488 channel is
restricted to pro-CCK-positive structures, which represent perikaryal cytoplasm of CCK-expressing neurons. (b) Staining in the Rhodamine
channel detects both pro-CCK and Pax2, because the Rhodamine-conjugated secondary anti-rabbit antibody was applied after both rabbit
primary antibodies (pro-CCK and Pax2). However, these can readily be distinguished because the Pax2 profiles are not labeled with Alexa
488 and because Pax2 staining is nuclear, whereas pro-CCK is cytoplasmic. (c) The same field scanned to reveal NeuN. (d) The merged image
shows pro-CCK-immunoreactivity in the perikaryal cytoplasm of cells (two marked with arrows) that have nuclei that are negative for Pax2
(asterisks). Two Pax2-positive cells, which lack pro-CCK, are indicated with arrowheads. All images are from a single optical section. Scale
bar = 20 μm [Color figure can be viewed at wileyonlinelibrary.com]
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TABLE 4 In situ hybridization analysis for CCK and VGLUT2
Number of neurons
with VGLUT2 mRNA
Number of neurons
with CCK mRNA
% of CCK neurons
with VGLUT2
% of VGLUT2 neurons
with CCK
I-II 772 (714–848) 60.0 (57–64) 93.3% (91.2–94.9%) 7.3% (6.1–8%)
III 404.7 (332–461) 148.3 (125–173) 97.6% (96.5–98.6%) 35.9% (34.9–36.7%)
In each case, the mean values for the three mice are shown, with the range in brackets.
FIGURE 3 In situ hybridization for cholecystokinin (CCK) and VGLUT2 in the dorsal horn. The section has been reacted with probes for the Cck
and Slc17a6 (VGLUT2) mRNAs and counterstained with NucBlue to reveal nuclei. The dashed line indicates the approximate position of the
lamina II-III border. (a) There are relatively few CCK-positive cells in the superficial dorsal horn (laminae I-II), but these are very numerous in
deeper laminae. (b) When labeling for both mRNAs is viewed together with staining for nuclei, it can be seen that there are numerous
VGLUT2-positive cells throughout the dorsal horn, and that many of these (particularly below the lamina II-III border) are CCK-positive. Insets
show the boxed regions at higher magnification. Each of these contains CCK-positive cells that are also labeled with the VGLUT2 probe. All
images are from a single optical section. Scale bar = 100 μm [Color figure can be viewed at wileyonlinelibrary.com]
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three mice, and found that none of these cells were PPTB-
immunoreactive (Figure 5a–d). In situ hybridization showed minimal
overlap: in sections from three mice that were reacted with probes
against Cck and Tac2 mRNA, we identified an average of 101 (range
90–113) Tac2 mRNA cells and 170 (109–235) Cck mRNA cells in lami-
nae I-III per animal. Only 1.6% (1–2%) of the Tac2 cells were Cck+,
while 1% (0.9–1.2%) of the Cck + cells were Tac2+ (Figure 5e).
3.3 | Partial overlap between CCK and substance P
populations
In sections from Tac1Cre mice that had been injected with AAV.flex.
eGFP, we found a similar distribution of eGFP-labeled (Tac1-expressing)
cells to that described previously (Dickie et al., 2019; Gutierrez-Mecinas
et al., 2017). These were concentrated in laminae I and II, with labeled
cells scattered through the deeper dorsal horn. Although most pro-
CCK-immunoreactive cells were different from those that were eGFP-
labeled, we found some overlap. In laminae I-II, double-labeled neu-
rons corresponded to 29% of the pro-CCK-immunoreactive cells, and
3% of those that were eGFP-labeled. In lamina III, the corresponding
proportions were 13 and 10%, respectively (Table 5, Figures 6a–d and
7). When we compared the distribution of Cck and Tac1 mRNAs in
wild-type mice, the results for laminae I-II were similar: double-labeled
cells corresponded to 21% of those with Cck and 3% of those with
Tac1 mRNA (Table 5, Figures 6e and 7). However, in lamina III we
found a considerably higher degree of overlap, with double-labeled
cells corresponding to 21% of those with Cck and 40% of those with
Tac1 mRNA (Table 5, Figures 6e and 7). The much higher proportion
of Tac1+ cells with Cck mRNA in lamina III may have resulted
from our failure to detect pro-CCK-immunoreactivity in some
CCK-expressing cells in this region (see above).
3.4 | Relationship of CCK to neurotensin, PKCγ,
and TRH
In sections from three wild-type mice that were immunoreacted for
pro-CCK, neurotensin, PKCγ, and NeuN, we identified a mean of
151.3 (range 125–185) pro-CCK-immunoreactive neurons in laminae
I-III and found that only 0.9% (0.7–1.1%) of these were neurotensin-
immunoreactive. However, 47.1% (41.1–51.4%) of the pro-CCK cells
were PKCγ-positive and these cells generally showed strong immu-
nostaining for PKCγ (Figure 8a–d).
Because we had previously found that many neurotensin-expressing
cells also showed moderate-strong labeling for PKCγ (Gutierrez-Mecinas
et al., 2016), we examined the relationship between neurotensin and
CCK among PKCγ-expressing cells. For this analysis, we excluded cells
that showed weak PKCγ-immunoreactivity, because we have reported
that many of these are PPTB-immunoreactive (Gutierrez-Mecinas et al.,
2016), and PPTB shows minimal coexpression with either CCK or neuro-
tensin. We identified a total of 838 cells with moderate-strong PKCγ-
immunoreactivity in sections from three mice, and found that 44% of
these were pro-CCK+ only, 40% were neurotensin+ only, while 2% had
both types of peptide immunoreactivity, and 15% had neither
(Figure 8a–d,h). This suggests that the great majority of dorsal horn neu-
rons that have significant levels of PKCγ express either CCK or neuro-
tensin. To provide further evidence for this, we also carried out in situ
hybridization for Cck, Nts, and Prkcg mRNAs and performed a similar
analysis. In this case, we set the threshold at 10 Prkcg mRNA transcripts
per cell in an attempt to exclude neurons that expressed low levels
FIGURE 4 Lack of colocalization of pro-cholecystokinin (CCK) and enhanced green fluorescent protein (eGFP) in tissue from the GRP::eGFP
mouse. (a–c) Scans from the superficial dorsal horn to show immunostaining for pro-CCK, eGFP, and NeuN. (d) The merged image reveals that
pro-CCK and eGFP are present in different neuronal populations. Two of the pro-CCK cells are indicated with arrows, while two eGFP-positive
cells are marked with arrowheads. Images are from three optical sections at 1 μm z-separation. Scale bar = 20 μm [Color figure can be viewed at
wileyonlinelibrary.com]
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of PKCγ. We identified 131 cells that met this criterion in sections
from three mice, and found that 33% of these cells were positive for
Cck mRNA only, 46% were positive for Nts mRNA only, while 6% were
positive for both peptide mRNAs, and 15% were negative for both
(Figure 8e–h).
TRH-expressing cells were detected with in situ hybridization,
and their distribution was similar to that reported previously (Allen
Spinal Cord Atlas, http://mousespinal.brain-map.org/). The cells were
relatively sparse, and were present in the inner part of lamina II and
the dorsal part of lamina III (Figure 9a,d). On average, 29.7 (22–35)
Trh mRNA-positive cells were identified in sections from three mice
that had been reacted with probes against Trh, Cck, and Prkcg
mRNAs, and 85% (81–89%) of these cells were Cck mRNA-positive
(Figure 9a–c). Because the Trh mRNA+ cells represent a very small
proportion of CCK-expressing cells we did not attempt to determine
the proportion of all CCK cells that expressed TRH. However, in a
band extending 40 μm either side of the lamina II-III border we identi-
fied between 86 and 103 CCK mRNA+ cells, and found that 25%
(21–28%) of these were TRH-positive. In these sections, Trh mRNA
was present in 46% (42–53%) of those CCK+ cells that had 10 or
more Prkcg mRNA transcripts. To further assess the relationship
between TRH and PKCγ, we analyzed sections reacted with this probe
combination, and also sections reacted with probes against Prkcg, Trh,
and Nts mRNAs. We identified 60.7 (58–64) Trh mRNA-positive cells,
TABLE 5 Extent of overlap of CCK and Tac1 populations
Number of
Tac1+ neurons
Number of CCK+
neurons
Number of
double-labeled
neurons
Double-labeled
neurons as % of
Tac1 neurons
Double-labeled
neurons as % of
CCK neurons
Lamina I-II Immunocytochemistry 342.3 (274–398) 37.7 (35–39) 11 (10–12) 3.3 (2.8–4.4) 29.2 (28.2–30.8)
In situ hybridization 301.3 (280–324) 43.7 (43–45) 9.3 (9–10) 3.1 (2.8–3.3) 21.4 (20.9–22.2)
Lamina III Immunocytochemistry 85 (68–105) 66.7 (59–71) 8.7 (3–13) 9.7 (4.4–12.4) 13.2 (4.3–18.3)
In situ hybridization 61.0 (50–74) 126.3 (64–192) 25.3 (16–39) 40.1 (32.0–52.7) 20.8 (17.1–25.0)
In each case, the mean values for the three mice are shown, with the range in brackets. For the immunocytochemical analysis of Tac1-expressing neurons,
we counted eGFP+ cells in sections from Tac1Cre mice that had received intraspinal injections of AAV.flex.eGFP.
FIGURE 5 Lack of colocalization of pro-cholecystokinin (CCK) and the neurokinin B precursor preprotachykinin B (PPTB) in the dorsal horn. (a–c)
Scans from lamina II and III of a section that had been reacted with antibodies against pro-CCK, PPTB, and NeuN. (d) The merged image reveals
that pro-CCK and PPTB are present in different neuronal populations. Two of the pro-CCK cells are indicated with arrows, while two PPTB-
positive cells are marked with arrowheads. Images are from four optical sections at 1 μm z-separation. (e) A single confocal optical plane from a
section that had been reacted with probes against CCK and Tac2 mRNAs, and counterstained with NucBlue. This field shows the region on either
side of the lamina II-III border. Many cells are positive for either CCK mRNA (green, two marked with arrows) or Tac2 mRNA (red, two marked
with arrowheads). Scale bars for (a–d) and for (e) = 20 μm [Color figure can be viewed at wileyonlinelibrary.com]
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and found that 91% (89–92%) of these were positive for Prkcg mRNA
(i.e., had four or more transcripts; Figure 9). The relationship between
TRH and neurotensin was examined in sections reacted with the latter
probe combination. We identified 31 (26–38) Trh mRNA+ cells and
138.7 (131–152) Nts mRNA+ cells in these sections. We found limited
co-expression, as only 4% (2.2–5.3%) of the Nts mRNA+ cells had Trh
mRNA, while 18% (12–21%) of Trh mRNA+ cells contained Nts mRNA
(Figure 9d–f).
FIGURE 6 Limited coexpression of cholecystokinin (CCK) and substance P in the dorsal horn. (a–d) Part of the superficial dorsal horn from a
Tac1Cre mouse that had been injected with AAV.flex.eGFP 8 days prior to perfusion fixation. (a–c) Show immunostaining for pro-CCK, enhanced
green fluorescent protein (eGFP) fluorescence, and NeuN immunoreactivity, while (d) shows a merged image. Numerous eGFP-positive
(substance P-expressing) cells can be seen in the upper part of the field (which corresponds to laminae I-II), and most of these lack pro-CCK (some
are indicated with asterisks). There are several pro-CCK-positive (eGFP-negative) cells in the lower part of the field, some marked with arrows. A
double-labeled cell is marked with an arrowhead. Images are from four optical sections at 1 μm z-spacing. (e) A single confocal optical plane from
a section that had been reacted with probes against CCK and Tac1 mRNAs, and counterstained with NucBlue. The field of view contains
numerous Tac1 mRNA-positive cells (three marked with asterisks), which form a dense band across the middle of lamina II. There are also several
CCK mRNA-positive cells (three shown with arrows), and most of these are located more ventrally. A single cell with both Tac1 and CCK mRNAs
is indicated with an arrowhead. Scale bars for (a–d) and for (e) = 20 μm [Color figure can be viewed at wileyonlinelibrary.com]
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4 | DISCUSSION
Our main findings were: (a) that CCK is expressed in <10% of excitatory
neurons in the superficial dorsal horn, but in a far higher proportion of
those in deeper laminae; (b) that these cells are largely separate from
those that express NKB or neurotensin, as well as from the population
defined by expression of eGFP in the GRP::eGFP mouse; (c) that there
is limited overlap with cells that express substance P; (d) that many of
the CCK cells express PKCγ, and together with neurotensin cells, these
account for ~85% of the cells with moderate or high levels of PKCγ
expression; and (e) that TRH is restricted to a small subset of the CCK
cells, accounting for around half of those that express PKCγ.
4.1 | Technical considerations
We used two different approaches as surrogate measures for gene
expression in dorsal horn neurons: in situ hybridization with RNAscope
that detects mRNA transcript numbers, and immunocytochemistry,
which reveals the proteins or peptides that are generated
from these mRNAs. Although the levels of mRNAs and their corre-
sponding proteins are correlated within individual cells, there is not a
direct relationship between them, for example due to variations in
post-transcriptional regulation and protein stability (Vogel & Marcotte,
2012). It is, therefore, not possible to predict how much mRNA in a par-
ticular neuron will lead to a specific level of protein expression in that
cell. Comparing these two techniques, the levels of protein or peptide,
as detected by immunocytochemistry, are presumably more important
in terms of function. However, knowledge of mRNA production forms
the basis for transcriptomic methods to define neuronal populations
(Häring et al., 2018), and also provides valuable information that is
needed for molecular/genetic approaches in which specific neurochem-
ical populations are to be targeted.
Although it is possible to combine immunocytochemistry with in
situ hybridization, and therefore confirm expression in the same cell
(Booker et al., 2017), we did not attempt to do this in the present
study, as we wished to retain optimal sensitivity offered by the RNA-
scope technique. Nonetheless, the consistency between patterns of
colocalization that we observed with the two techniques strongly sug-
gests that in general, they were detecting equivalent populations.
However, as the RNAscope method allows identification of individual
mRNA molecules, it is likely to reveal cells with very low levels of gene
expression, which may be missed with immunocytochemistry.
4.2 | Neurochemical populations among dorsal horn
excitatory interneurons
Classification schemes for dorsal horn neurons have been based
mainly on the laminar location, morphology, electrophysiological prop-
erties, and neurochemistry of the cells (Abraira et al., 2017; Graham,
Brichta, & Callister, 2007; Grudt & Perl, 2002; Yasaka, Tiong, Hughes,
Riddell, & Todd, 2010). Among the four neurochemical populations
that we had previously identified, the neurotensin and NKB cells had
certain features in common, as they were both concentrated on either
side of the lamina II-III border, and both included cells that expressed
PKCγ. We have recently provided evidence that the other two popu-
lations differed from each other in both morphological and electro-
physiological properties with those that express substance P
corresponding to radial cells (which generally show delayed firing) and
the GRP-GFP cells resembling a population that had been defined by
Grudt and Perl (2002) as “transient central cells” (Dickie et al., 2019).
Häring et al. (2018) used clustering of transcriptomic data to define
15 populations of excitatory neuron, which they named Glut1-15. Their
analysis generally supports our earlier findings, by showing that mRNAs
for substance P, neurotensin, and NKB are highly expressed by differ-
ent populations: Glut10-11 for substance P, Glut4 for neurotensin, and
Glut5-6 for NKB. However, both of their substance P populations
(Glut10 and 11) include many cells in deeper laminae, and therefore
extend beyond the lamina II radial cell population that we have identi-
fied (Dickie et al., 2019). Häring et al. did not define a population specif-
ically associated with GRP expression, and they reported that GRP
mRNA was present in cells belonging to several of their populations
(Glut5-12). Although virtually all eGFP-expressing cells in the GRP-
eGFP mouse contain GRP mRNA, many cells with GRP mRNA do not
express GFP in this line (Dickie et al., 2019; Solorzano et al., 2015), and
this suggests that eGFP is restricted to a subset of the GRP-expressing
cells. We have found that at least some of these GRP-eGFP cells con-
tain mRNA for the neuromedin U receptor 2 (Nmur2; AMB,
FIGURE 7 Quantitative data for coexpression of cholecystokinin
(CCK) and substance P in the dorsal horn. The bar chart shows the
mean numbers of cells in laminae I-II and lamina III that were defined
as expressing CCK, Tac1 (the gene coding for substance P), or both
peptides, based on immunocytochemistry (ICC) or in situ hybridization
(ISH). The immunocytochemical detection of pro-CCK was performed
on 3 Tac1Cre mice that had received intraspinal injections of AAV.flex.
eGFP, and eGFP-containing cells were defined as Tac1-positive. In
situ hybridization was performed with RNAscope and single optical
sections from three wild-type mice were analyzed. Cells containing
four or more transcripts for CCK or Tac1 mRNAs were defined as
positive for the respective peptide. For further details, see Table 5
[Color figure can be viewed at wileyonlinelibrary.com]
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unpublished data), and these may therefore correspond to the Glut8
population, in which Nmur2 mRNA is enriched.
Häring et al. (2018) assigned CCK-expressing neurons to three sep-
arate clusters: Glut1, 2, and 3. These differed somewhat in laminar loca-
tion, with cells belonging to Glut2 being scattered through laminae I-II,
those in Glut3 forming a compact band in laminae IIi-III, and those in
Glut1 (the largest population) being virtually restricted to the deep dor-
sal horn (laminae III-V). In addition, expression of TRH was limited to
the Glut3 population. In the present study, we found a relatively small
number of CCK+ cells in laminae I-II, and most of these are likely to
belong to the Glut2 population of Häring et al. The more numerous
CCK-expressing cells that were distributed throughout the deeper lami-
nae presumably correspond mainly to the Glut1 and Glut3 populations,
with the subset that coexpressed TRH representing the Glut3 cells. The
very limited overlap between pro-CCK-immunoreactive cells and those
that were neurotensin- or PPTB-immunoreactive is consistent with
the results of Häring et al., and provides further evidence that these
neuropeptides are expressed in different populations of excitatory
interneurons. We did see a moderate degree of overlap between Tac1
and CCK, with around a quarter of CCK+ cells in laminae I-II being
Tac1-positive. However, these only accounted for 3% of Tac1 cells,
indicating that CCK is seldom, if ever, expressed by substance P radial
FIGURE 8 The relationship of pro-cholecystokinin (CCK) and neurotensin to protein kinase Cγ (PKCγ) in the dorsal horn. (a–c) A projection of
three optical sections (1 μm z-separation) through the lamina II-III border region scanned to reveal immunoreactivity for pro-CCK, neurotensin
(NTS), and PKCγ. Cell bodies of five neurons with strong to moderate PKCγ staining are visible. (d) The merged image shows that two of these are
neurotensin-immunoreactive (arrowheads), while the other three are pro-CCK-immunoreactive (arrows). In each case, immunostaining for the
neuropeptide/precursor can be seen in the perikaryal cytoplasm just inside the ring of PKCγ-immunostaining, which represents the plasma
membrane. (e–g) In situ hybridization in a section that had been reacted with probes for CCK, neurotensin, and PKCγ mRNAs and counterstained
with NucBlue. Several PKCγ+ cells are present in this field, and six of these are marked. Three (arrows) are positive for CCK mRNA and two
(arrowheads) for neurotensin mRNA, while one (asterisk) contains mRNAs for both CCK and neurotensin. The in situ hybridization images were
obtained from a single optical section. (h) Quantitative analysis of the proportions of PKCγ cells that were positive for CCK and/or NTS detected
with either immunocytochemistry (ICC) or in situ hybridization (ISH). The bar chart shows the results for cells with strong to moderate PKCγ-
immunoreactivity (ICC) or that had 10 or more Prkcg mRNA transcripts (ISH). In each case, these have been divided into those that were positive
for CCK only (green), neurotensin only (red), or both CCK and neurotensin (orange). Cells that were negative for both peptides are represented as
gray bars. In each case, data from three animals were pooled. Scale bars for (a–d) and for (e-g) = 20 μm [Color figure can be viewed at
wileyonlinelibrary.com]
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cells in lamina II (Dickie et al., 2019). The cells that express both CCK
and Tac1 in this region could belong to either Glut9 or Glut10, because
both peptides are significantly expressed in these clusters, and they
include cells in the superficial dorsal horn. CCK and Tac1 showed a
higher frequency of coexpression in lamina III and based on similar cri-
teria, these could belong to either Glut10 or Glut14.
Peirs et al. (2015) have described a population of deep dorsal horn
cells that transiently express VGLUT3, and have shown that these are
required for mechanical hypersensitivity in both neuropathic and
inflammatory pain states. It will, therefore, be of interest to know
whether these “transient VGLUT3” neurons overlap with the CCK cells,
and also how they fit into the classification scheme of Häring et al.
4.3 | CCK expression by PKCγ cells
Although Häring et al. (2018) found mRNA for PKCγ distributed
across several different clusters (Glut2-7), many earlier studies had
identified a distinctive population of excitatory interneurons that
showed PKCγ immunoreactivity (Abraira et al., 2017; Alba-Delgado
et al., 2015; Hughes, Averill, King, Molander, & Shortland, 2008; Lu
et al., 2013; Malmberg et al., 1997; Martin, Liu, Wang, Malmberg, &
Basbaum, 1999; Miraucourt et al., 2007; Mori, Kose, Tsujino, &
Tanaka, 1990; Neumann, Braz, Skinner, Llewellyn-Smith, & Basbaum,
2008; Polgár, Fowler, McGill, & Todd, 1999). These cells are concen-
trated in laminae IIi and III, and their dendrites form a dense plexus in
lamina IIi. Knock-out of PKCγ in mice leads to a reduction in mechani-
cal and thermal hypersensitivity following peripheral nerve injury
(Malmberg et al., 1997). In addition, a selective PKCγ antagonist was
found to reduce the mechanical allodynia resulting from injection of
strychnine into the cisterna magna in rats (Miraucourt et al., 2007).
Anatomical studies have shown that PKCγ cells are innervated by
myelinated low-threshold mechanoreceptive afferents, and have pro-
vided evidence that they respond to innocuous mechanical stimuli
(Neumann et al., 2008). Taken together with electrophysiological and
pharmacological data (Lu et al., 2013; Miraucourt et al., 2007;
Torsney & MacDermott, 2006), this has led to the suggestion that
PKCγ cells form part of a polysynaptic pathway that links low-threshold
mechanoreceptive input to lamina I projection neurons. This pathway is
normally closed due to feedforward inhibitory mechanisms, but these
may become ineffective following nerve injury, resulting in mechanical
allodynia (Lu et al., 2013). Interestingly, there is evidence that the PKCγ
cells do not contribute to mechanical hyperalgesia in inflammatory pain
states (Peirs et al., 2015; Peirs & Seal, 2016).
We had previously shown that many of the cells with moderate-
strong PKCγ immunoreactivity contained neurotensin (Gutierrez-
Mecinas et al., 2016). Although PPTB cells were often PKCγ-positive,
the level of PKCγ in these cells was generally much lower, and they
may therefore not contribute significantly to the allodynia attributed
to PKCγ, or to PKCγ-expressing neurons. Here, we show that the
great majority of cells with moderate-high levels of PKCγ express
either neurotensin or CCK. This finding was surprising, since Abraira
et al. (2017) recently reported that there was minimal overlap
between CCK and PKCγ cells. In their study, CCK cells were identified
in a CCKCreER mouse line, while PKCγ was detected with immunocyto-
chemistry. Cre-mediated recombination in this line is dependent on
nuclear translocation of Cre following treatment with tamoxifen, and
it may be that this was not sufficient in this population of CCK-
expressing cells.
FIGURE 9 The relationship of thyrotropin-releasing hormone (TRH)-expressing dorsal horn neurons to cholecystokinin (CCK), protein kinase Cγ
(PKCγ), and neurotensin. (a–c) A scan through laminae II and III from a section reacted with probes against TRH, CCK, and PKCγ mRNAs, and
counterstained with NucBlue. Three TRH+ cells are marked with arrows, and all of these are positive for both CCK and PKCγ mRNAs. Asterisks
indicate two PKCγ cells that lack message for TRH and CCK, while the arrowheads show two CCK cells that are negative for TRH and PKCγ. (d–f)
A scan through the equivalent region from a section reacted with probes against TRH, neurotensin, and PKCγ mRNAs, and counterstained with
NucBlue. Two TRH+ cells that contain mRNA for PKCγ, but not for neurotensin, are indicated with arrows. The arrowheads point to two cells
that are positive for neurotensin and PKCγ mRNA, but negative for TRH mRNA. All images were obtained from single optical sections. Scale
bar = 20 μm [Color figure can be viewed at wileyonlinelibrary.com]
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Around half of the CCK+/PKCγ+ cells contained mRNA for TRH,
and as this is virtually restricted to the Glut3 cluster of Häring et al.
(2018), these cells presumably belong to this population. As PKCγ was
expressed at significant levels by cells in their Glut2 (but not Glut1)
cluster, the CCK+/PKCγ+ neurons that lacked TRH may form part of
the Glut2 population. Interestingly, Alba-Delgado et al. (2015) identi-
fied two distinct populations of PKCγ-expressing cells in the rat spinal
trigeminal nucleus, based on differences in morphological and electro-
physiological properties. It will, therefore, be important to determine
how the classes defined by Alba-Delgado et al. are related to the dif-
ferent neuropeptide-expressing classes identified here.
4.4 | Role of CCK-expressing cells in the dorsal horn
The principal function that has been attributed to CCK at the spinal
level is a tonic reduction of the antinociceptive action of opioids, and
this is thought to be mediated mainly by CCKB receptors (Wiesenfeld-
Hallin, Xu, & Hokfelt, 2002). It has also been reported that CCK con-
tributes to the development of tolerance to the analgesic effects of
transcutaneous electrical nerve stimulation in a rat model of inflamma-
tory arthritis, again involving an anti-opioid mechanism (DeSantana,
da Silva, & Sluka, 2010). A recent report suggests that the anti-opioid
action of CCK may involve hetero-dimerization of μ-opioid and CCKB
receptors (Yang et al., 2018). As the highest density of μ-opioid recep-
tors is in the superficial dorsal horn (Arvidsson et al., 1995), it is sur-
prising that CCK-expressing cells are far more numerous in laminae
III-IV. However, CCK is presumably released via a nonsynaptic mecha-
nism (“volume transmission”) and may diffuse from release sites in the
deeper laminae to the superficial dorsal horn.
Because the CCK cells are glutamatergic, it is likely that their main
action will be mediated by synaptically released glutamate. Two recent
studies have tested the effects of ablating CCK-expressing dorsal horn
neurons, in both cases using a mouse line in which Cre recombinase was
knocked into the CCK locus (Abraira et al., 2017; Liu et al., 2018).
Abraira et al. reported that mice in which CCK cells had been ablated
could not distinguish between objects with different textures, and failed
to show prepulse inhibition in response to a light air puff applied before
an acoustic stimulus. Liu et al. showed that ablation of these cells
reduced mechanical allodynia in the spared nerve injury model of neuro-
pathic pain, and significantly decreased the number of dorsal horn neu-
rons that showed Fos in response to brush stimulation in these mice.
Together, these findings indicate that dorsal horn CCK cells have impor-
tant roles in the perception of tactile stimuli in naïve animals, and that
they are also involved in mechanical allodynia in neuropathic pain states.
The CCK cells represent a large subset of excitatory interneurons,
accounting for around a third of those in deeper laminae, and it is there-
fore not surprising that ablation results in a dramatic behavioral pheno-
type. Our findings, together with those of Häring et al. (2018), suggest
that CCK cells include functionally distinct subsets, such as those that
co-express PKCγ. The extensive overlap between CCK and PKCγ
that we observed, taken together with earlier studies that have
implicated PKCγ cells in neuropathic pain, raise the possibility that the
CCK+/PKCγ+ cells may be particularly important for the development
of mechanical allodynia. In future studies, it will be important to deter-
mine the contribution of the different neuropeptide-expressing subsets
of PKCγ neurons to the development of allodynia in neuropathic pain
states.
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